Abstract

In recent years’ obesity which is one among the metabolic syndrome is a leading health problem which can be corelated to dyslipidaemia – “prayaha snehat meda pravaradhyet”, implying the factor that excessive sneha(oleation) is responsible for excessive production of meda dhatu (fatty tissue) and such excessively accumulated meda dhatu (fatty tissue) causing avarodha (obliteration) of other dhatu(tissues) leading to medoroga(dyslipidaemia) or else it is taken as sthoulya (Obesity). Obesity is always associated with dyslipidaemia and other such metabolic disorders. There is an exact explanation to this pathology in Ayurveda and our acharyas have mentioned proper shamana aushadi (alleviating therapy) which can tackle both obesity as well as dyslipidaemia together. Hence our aim for this case report is to find out the efficacy of Vrikshamla (Garcinia Cambogia) in the management of sthoulya (Obesity) and dyslipidaemia and objectives that were assessed are body weight, BMI, body circumference and lipid profile of the patient. A 32-year-old male patient was a known case of obesity and diagnosed with dyslipidaemia based on the laboratory investigation. Patient was not a known case of any other metabolic disorders and administered with shamana aushadi (alleviating therapy) vrikshamla 2gms per day for 60 days. Patient was assessed before and after treatment with the subjective and objective parameters were taken up for the study which showed the drastic improvement in weight reduction of 6kgs and BMI was reduced to 29.2 from 32.2 and shows better results in lipid profile as well. Drug Vrikshamala (extract) which has amla(sour), katu(pungent) and madhura(sweet) rasa(taste) with laghu(lightness) and usna(hot) guna(properties) in predominance and having the kapha medohara property helps in agnisam dhukshana (stimulate digestive power) and does the ama sanchaya, clears the srotorodha (obstruction of channels) was profoundly successful in reducing weight, BMI and lipid profile of a patient. Thus vrikshamala shows a better efficacy against sthoulya(obesity) and in dyslipidemia.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.